Literature DB >> 31313102

A 5-year study of human parechoviruses in children living in bad sanitation conditions and non-polio acute flaccid paralysis children from Greece.

Karageorgou Ioulia1, Pogka Vasiliki1, Labropoulou Stavroula1, Angelakis Emmanouil2,3, Mentis Andreas1.   

Abstract

In Greece, data for human parechoviruses (HPeVs) are scarce and our aim was to conduct a large scale study to determine for the first time their occurrence. Under the spectrum of surveillance, we retrospectively screened stool specimens obtained from 71 children with acute flaccid paralysis (AFP) symptoms and from 311 individuals in high-risk population groups such as children living in bad sanitation conditions for HPeVs presence by rRT-PCR targeting the 5' UTR. All positive samples were then genotyped by targeting the HPeVs VP1 region. Totally, 15/311 (5%) stool samples from children living in bad sanitation conditions and 4/71 (6%) from the non polio AFP children were positive for HPeVs. Sequencing analysis revealed that genotypes HPeV1 (n = 4/15), HPeV5 (n = 2/15), and HPeV6 (n = 2/15) were circulating among Roma children population whereas HPeV1 (n = 1/4) and HPeV5 (n = 1/4) were circulating in children with AFP-like symptoms. We did not obtain a seasonality motive among HPeV1 or HPeV5 genotypes whereas HPeV6 was detected only in July. Phylogenetic analysis showed that Greek HPeVs strains are clustered together with HPeV strains circulating in other European countries during the same period. We describe the presence of HPeVs in Greece, and we enforce that their diagnosis should be considered in children with neurological outcome such as non-polio AFP.

Entities:  

Keywords:  Greece; Human parechoviruses; Nomadic Roma; Non-polio acute flaccid paralysis

Year:  2019        PMID: 31313102     DOI: 10.1007/s10096-019-03627-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Human parechoviruses are frequently detected in stool of healthy Finnish children.

Authors:  Pekka Kolehmainen; Sami Oikarinen; Marjaleena Koskiniemi; Olli Simell; Jorma Ilonen; Mikael Knip; Heikki Hyöty; Sisko Tauriainen
Journal:  J Clin Virol       Date:  2012-03-08       Impact factor: 3.168

Review 2.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

3.  Synthetic peptides for efficient discrimination of anti-enterovirus antibodies at the serotype level.

Authors:  John G Routsias; Maria D Mavrouli; Georgia Antonaki; Nikolaos Spanakis; Athanassios Tsakris
Journal:  Peptides       Date:  2014-06-11       Impact factor: 3.750

Review 4.  The need for treatment against human parechoviruses: how, why and when?

Authors:  Joanne G Wildenbeest; Heli Harvala; Dasja Pajkrt; Katja C Wolthers
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

5.  Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain.

Authors:  María Cabrerizo; María Díaz-Cerio; Carmen Muñoz-Almagro; Núria Rabella; David Tarragó; María Pilar Romero; María José Pena; Cristina Calvo; Sonia Rey-Cao; Antonio Moreno-Docón; Inés Martínez-Rienda; Almudena Otero; Gloria Trallero
Journal:  J Med Virol       Date:  2016-08-22       Impact factor: 2.327

6.  Prevalence of human parechovirus in the Netherlands in 2000 to 2007.

Authors:  Sabine van der Sanden; Erwin de Bruin; Harry Vennema; Caroline Swanink; Marion Koopmans; Harrie van der Avoort
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948

7.  Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011.

Authors:  S M G van der Sanden; M P G Koopmans; H G A M van der Avoort
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-06-19       Impact factor: 3.267

Review 8.  Enterovirus and parechovirus infection in children: a brief overview.

Authors:  S C M de Crom; J W A Rossen; A M van Furth; C C Obihara
Journal:  Eur J Pediatr       Date:  2016-05-07       Impact factor: 3.183

9.  Isolation and characterization of novel human parechovirus from clinical samples.

Authors:  Kanako Watanabe; Masayasu Oie; Masaya Higuchi; Makoto Nishikawa; Masahiro Fujii
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Comparison of four nasal sampling methods for the detection of viral pathogens by RT-PCR-A GA(2)LEN project.

Authors:  Irini S Spyridaki; Ioannis Christodoulou; Lieke de Beer; Vegard Hovland; Marcin Kurowski; Agnieszka Olszewska-Ziaber; Kai-Håkon Carlsen; Karin Lødrup-Carlsen; Cornelis M van Drunen; Marek L Kowalski; Richard Molenkamp; Nikolaos G Papadopoulos
Journal:  J Virol Methods       Date:  2008-12-19       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.